Funding Received
$2.1 Million in 2 Rounds from 3 Investors
Most Recent Funding
$2 Million Series A on September 26, 2013
Founded:
2012
Headquarters:
Palo Alto, CA
Description:
Neurotracks is a company that develops tools that enable physicians to predict Alzheimer’s disease before the symptoms appear.
Categories:
Biotechnology
Website:
http://neurotrack.com

Detailed Description

Update

Neurotrack's technology can diagnose Alzheimer’s Disease up to six years before symptoms occur. Based on ground-breaking research, it enables pharmaceutical companies and researchers to recruit qualified candidates for clinical trials, and more effectively measure drug efficacy, speeding up drug discovery and development.

Neurotrack is also becoming the standard for early clinical screening of Alzheimer’s and dementia related disorders.

Funding Rounds (2) - $2.1M

Update

Investors (3)

Update

Offices/Locations (1)

Update
  • Headquarters

    120 Hawthorne Ave

    Palo Alto, CA 94301

    USA

Images (1)

Update
  • Edd7d61008d3f1411e6a95911af7af5a